Regulating protective immunity in atherosclerosis.
Nilsson
Jan
J
D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology / Q000378:metabolism; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics; D001161:Arteriosclerosis / Q000209:etiology / Q000276:immunology* / Q000517:prevention & control; D001324:Autoantigens / Q000276:immunology*; D015704:CD4 Antigens / Q000235:genetics / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000378:metabolism; D018450:Disease Progression; D005620:Freund's Adjuvant / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007114:Immunization; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000276:immunology; D007249:Inflammation / Q000150:complications; D007694:Killer Cells, Natural / Q000276:immunology; D008077:Lipoproteins, LDL / Q000276:immunology* / Q000627:therapeutic use; D008211:Lymphocyte Cooperation; D008315:Malondialdehyde / Q000031:analogs & derivatives* / Q000276:immunology; D051379:Mice; D018345:Mice, Knockout; D008817:Mice, Mutant Strains; D011971:Receptors, Immunologic / Q000378:metabolism; D051116:Receptors, Scavenger; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology / Q000378:metabolism
D001057:Apolipoproteins E; D001324:Autoantigens; D015704:CD4 Antigens; D016207:Cytokines; D007074:Immunoglobulin G; D008077:Lipoproteins, LDL; D011971:Receptors, Immunologic; D051116:Receptors, Scavenger; C502964:malondialdehyde-low density lipoprotein, mouse; C099252:oxidized low density lipoprotein; D008315:Malondialdehyde; D005620:Freund's Adjuvant